NCT05082597|Completed
Loading search results
Sponsor study identifier
interventional
20
1 country
1
Study Start
October 13, 2021
Actual (reported)Primary Completion
March 31, 2025
Actual (reported)Study Completion
March 31, 2025
Actual (reported)Axillary web syndrome(AWS) is common complication of breast cancer surgery. Overall, AWS affects more than a half of the patient receiving axillary lymph node dissection. The symptoms of AWS include pain, limited function and range of motion. Geater risk of secondary lymphedema was found if the patient developed AWS during the first postoperative year. ESWT was used for treating myofascial pain for decades. Low energy ESWT combined with complex decongestive therapy had a benefit on shoulder joint ROM and skin thickness improvement in patients with BCRL in recently studies. Investigators wonder if ESWT can also be applied to patients with axillary web syndrome for increasing ROM and relieving pain. The aim of this study was to evaluate the therapeutic effects of low energy ESWT in patients with axillary web syndrome.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 31, 2025
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 24, 2021
Actual (reported)October 13, 2021
Actual (reported)October 19, 2021
Actual (reported)March 31, 2025
Actual (reported)March 31, 2025
Actual (reported)Shoulder range of motion
Flexion, extension, external rotation, internal rotation, abduction over upper limbs
2 months
Pain score
Visual Analogue Scale (0-10 points, higher score represented higher degree of pain)
2 months
Muscle strength
2 months
Upper limb functional score
2 months
Receive low energy extracorporeal shock wave therapy
Therapeutic sessions: 4(once a week, for 4 weeks) Total dosage: 2500 shoots over axillary cord lesion (1000 over most fibrotic area, 500 over upper arm, 500 over forearm, 500 over other area) Energy: 0.056-0.065mJ/mm2
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Taichung Veterans General Hospital
Taichung, Taichung City, 407219, Taiwan
Yu Lin Tsai, MD
Department of Physical Medicine and Rehabilitation
20 participants (actual enrollment reported by the registry).
First Submitted
September 24, 2021
First Posted
October 19, 2021
Study Start
October 13, 2021
Actual (reported)Extracorporeal Shock Wave in the Treatment of Trigger Finger
Contact the study team to confirm eligibility.
Primary Completion
March 31, 2025
Actual (reported)Study Completion
March 31, 2025
Actual (reported)Last Updated
September 9, 2025
Record last verified: 2025-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: